Publicaciones en colaboración con investigadores/as de Novartis (Sweden) (7)

2020

  1. NT-proBNP Response to Sacubitril/Valsartan in Hospitalized Heart Failure Patients With Reduced Ejection Fraction: TRANSITION Study

    JACC: Heart Failure, Vol. 8, Núm. 10, pp. 822-833

2019

  1. Effects of serelaxin in patients with acute heart failure

    New England Journal of Medicine, Vol. 381, Núm. 8, pp. 716-726

  2. Initiation of sacubitril/valsartan in haemodynamically stabilised heart failure patients in hospital or early after discharge: primary results of the randomised TRANSITION study

    European Journal of Heart Failure, Vol. 21, Núm. 8, pp. 998-1007

2017

  1. Secukinumab in Active Rheumatoid Arthritis: A Phase III Randomized, Double-Blind, Active Comparator– and Placebo-Controlled Study

    Arthritis and Rheumatology, Vol. 69, Núm. 6, pp. 1144-1153

2007

  1. Pharmacokinetics and variability of mycophenolic acid from enteric-coated mycophenolate sodium compared with mycophenolate mofetil in de novo heart transplant recipients

    Clinical Transplantation, Vol. 21, Núm. 1, pp. 18-23

2001

  1. Removal of bowel aerobic gram-negative bacteria is more effective than immunosuppression with cyclophosphamide and steroids to decrease natural α-Galactosyl IgG antibodies

    Xenotransplantation, Vol. 8, Núm. 1, pp. 15-23

1999

  1. Sustained decrease of serum anti-galactose α1-3-galactose antibodies in baboons by removing aerobic gram-negative bacteria from the bowel

    Transplantation Proceedings